Emory University

Emory University Account Receivable Division, doing business as Emory Conference Center, is a registered entity with the U.S. federal government, classified as an "Other Not For Profit Organization." Emory University, located in Atlanta, Georgia, is a renowned private research university founded in 1836. The institution provides a wide range of goods and services to the federal government through both contract and grant awards. These services primarily focus on medical research, healthcare innovations, and scientific advancements, leveraging Emory's strong academic and research capabilities.

In terms of federal contract awards, Emory University has demonstrated expertise in developing cutting-edge medical treatments. A notable example is their recent definitive, firm-fixed price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. This contract, valued at $749,998.20, involves the development of "FLUVID," an innovative dry powder, inhaled, mRNA-based treatment for both influenza and COVID-19. The contract has a performance period ending on March 31, 2026, and does not have a set-aside designation. This project showcases Emory's capabilities in addressing urgent public health needs through advanced pharmaceutical research and development.

Emory University's involvement in federal grant sub-awards further illustrates its diverse research portfolio. One sub-award, under Georgia State University Research Foundation Inc. as the prime grantee, involves recruiting participants with mild cognitive impairment or early Alzheimer's disease for a research project. This work includes identifying potential participants from previous relevant projects, reaching out to communities and aging care facilities, and pre-screening candidates based on specific criteria. Another sub-award, with Ann & Robert H. Lurie Children's Hospital of Chicago as the prime grantee, focuses on a clinical trial involving allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome. These sub-awards demonstrate Emory's significant contributions to neurological and cardiovascular research, highlighting the institution's role in advancing medical knowledge and treatment options across various fields of study.